Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Natalia Paola Catoira, Luciano Viale, Guillermo Di Girolamo & Claudio Gonzalez. (2014) New centrally acting agents for appetite control: from biological mechanisms to clinical efficacy. Current Medical Research and Opinion 30:6, pages 961-969.
Read now
Read now
Mariana P Monteiro. (2014) Obesity vaccines. Human Vaccines & Immunotherapeutics 10:4, pages 887-895.
Read now
Read now
Dragana Nikolic, Peter P Toth, Alessandra Ferlita, Vittoria Di Bartolo, Giuseppe Montalto, Maciej Banach & Manfredi Rizzo. (2014) Novel anti-obesity drugs and plasma lipids. Clinical Lipidology 9:2, pages 179-187.
Read now
Read now
Articles from other publishers (21)
Harold E. Bays, Angela Fitch, Sandra Christensen, Karli Burridge & Justin Tondt. (2022) Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Obesity Pillars 2, pages 100018.
Crossref
Crossref
Sanjay Sharma, Komal S. Aware, Ketan Hatware & Kiran Patil. (2020) Chemistry, Analysis, Pharmacokinetics and Pharmacodynamics Aspects of Lorcaserin, a Selective Serotonin 5-HT2C Receptor Agonist: An Update. Mini-Reviews in Medicinal Chemistry 20:9, pages 768-778.
Crossref
Crossref
Md Nurunnabi, Kelly N. IbsenEden E. L. TannerSamir Mitragotri. (2019) Oral ionic liquid for the treatment of diet-induced obesity. Proceedings of the National Academy of Sciences 116:50, pages 25042-25047.
Crossref
Crossref
H. Bays, C. Perdomo, E. Nikonova, R. Knoth & M. Malhotra. (2018) Lorcaserin and metabolic disease: weight‐loss dependent and independent effects. Obesity Science & Practice 4:6, pages 499-505.
Crossref
Crossref
Ruth Oliveira, Rafael Câmara, Jessyka Monte, Rony Viana, Karoline Melo, Moacir Queiroz, Luciana Filgueira, Lila Oyama & Hugo Rocha. (2018) Commercial Fucoidans from Fucus vesiculosus Can Be Grouped into Antiadipogenic and Adipogenic Agents. Marine Drugs 16:6, pages 193.
Crossref
Crossref
Sofia Dias, Sílvia Paredes & Laura Ribeiro. (2018) Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose Tissue. International Journal of Endocrinology 2018, pages 1-21.
Crossref
Crossref
Harold E. Bays, Peter H. Jones, Terry A. Jacobson, David E. Cohen, Carl E. Orringer, Shanu Kothari, Dan E. Azagury, John Morton, Ninh T. Nguyen, Eric C. Westman, Deborah B. Horn, Wendy Scinta & Craig Primack. (2016) Lipids and bariatric procedures part 1 of 2: Scientific statement from the National Lipid Association, American Society for Metabolic and Bariatric Surgery, and Obesity Medicine Association: EXECUTIVE SUMMARY. Journal of Clinical Lipidology 10:1, pages 15-32.
Crossref
Crossref
Harold E. Bays, Peter H. Jones, Terry A. Jacobson, David E. Cohen, Carl E. Orringer, Shanu Kothari, Dan E. Azagury, John Morton, Ninh T. Nguyen, Eric C. Westman, Deborah B. Horn, Wendy Scinta & Craig Primack. (2016) Lipids and bariatric procedures part 1 of 2: Scientific statement from the National Lipid Association, American Society for Metabolic and Bariatric Surgery, and Obesity Medicine Association: FULL REPORT. Journal of Clinical Lipidology 10:1, pages 33-57.
Crossref
Crossref
Matthias GieseMatthias Giese. 2016. Introduction to Molecular Vaccinology. Introduction to Molecular Vaccinology
335
364
.
Hea‐Jong Chung, Jae G. Yu, In‐Ah Lee, Ming‐Jie Liu, Yan‐Fei Shen, Satya P. Sharma, Mohammad A. H. M. Jamal, Jun‐Hyun Yoo, Hyeon‐Jin Kim & Seong‐Tshool Hong. (2016)
Intestinal removal of free fatty acids from hosts by
Lactobacilli
for the treatment of obesity
. FEBS Open Bio 6:1, pages 64-76.
Crossref
Crossref
Martin F. Casey & Jeffrey I. Mechanick. (2014) Anti-Obesity Agents and the US Food and Drug Administration. Current Obesity Reports 3:3, pages 361-367.
Crossref
Crossref
Sara Andrade, Marcos Carreira, Felipe F. Casanueva, Polly Roy & Mariana P. Monteiro. 2014. Molecular Vaccines. Molecular Vaccines
463
476
.
Katrin Rössger, Ghislaine Charpin-El-Hamri & Martin Fussenegger. (2013) A closed-loop synthetic gene circuit for the treatment of diet-induced obesity in mice. Nature Communications 4:1.
Crossref
Crossref
Katherine A. Lyseng-Williamson & Sheridan M. Hoy. (2013) Lorcaserin: a guide to its use in chronic weight management. Drugs & Therapy Perspectives 29:10, pages 303-308.
Crossref
Crossref
Marietta Charakida, Dimitris Tousoulis & Nicholas Finer. (2013) Drug treatment of obesity in the cardiovascular patient. Current Opinion in Cardiology 28:5, pages 584-591.
Crossref
Crossref
Harold E. Bays, Peter P. Toth, Penny M. Kris-Etherton, Nicola Abate, Louis J. Aronne, W. Virgil Brown, J. Michael Gonzalez-Campoy, Steven R. Jones, Rekha Kumar, Ralph La Forge & Varman T. Samuel. (2013) Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association. Journal of Clinical Lipidology 7:4, pages 304-383.
Crossref
Crossref
Sheridan M. Hoy. (2013) Lorcaserin: A Review of its Use in Chronic Weight Management. Drugs 73:5, pages 463-473.
Crossref
Crossref
Dragana Nikolic, Niki Katsiki, Giuseppe Montalto, Esma Isenovic, Dimitri Mikhailidis & Manfredi Rizzo. (2013) Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches. Nutrients 5:3, pages 928-948.
Crossref
Crossref
Ioanna Paspala, Niki Katsiki, Dorothea Kapoukranidou, Dimitri P Mikhailidis & Anna Tsiligiroglou-Fachantidou. (2012) The Role of Psychobiological and Neuroendocrine Mechanisms in Appetite Regulation and Obesity. The Open Cardiovascular Medicine Journal 6:1, pages 147-155.
Crossref
Crossref
Marietta Charakida & Nicholas Finer. (2012) Drug Treatment of Obesity in Cardiovascular Disease. American Journal Cardiovascular Drugs 12:2, pages 93-104.
Crossref
Crossref
Muhammad Yasir Qureshi, James D. Wilkinson & Steven E. Lipshultz. 2012. Pediatric Metabolic Syndrome. Pediatric Metabolic Syndrome
199
215
.